nondiabetic
Prospectively, uromodulin was lowest in patients with T2DM at baseline, higher in initially nondiabetic subjects who developed diabetes during follow-up (FU) and highest among nondiabetic patients (147.7  69.9 vs 164  67 vs 179.9  82.2ng/mL, Ptrend<0.001).